← Leaderboards
Patrick McKenna Glassman
University Of Pennsylvania
$1,052,716
Attributed
$1,052,716
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $401.9K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,052,716 · 2
By mechanism
R00$746,968 · 1
K99$305,748 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Vladimir R Muzykantov$31,969,177
- Martin Kneyber$3,209,610
- Rodney Wiersma$3,677,725
- Robert W Neumar$9,069,007
- Ellen S. Heber-Katz$7,979,062
Others in their field
Other Emerging Leaders on “Cytolysis”
- Florence Burleson$4,647,424
- Brandon Lee Garcia · Kansas State University$4,122,069
- Jonathan D Posner · University Of Washington$3,767,448
- Paul John Norman · University Of Colorado Denver$3,646,053
- Benjamin G Vincent · Univ Of North Carolina Chapel Hill$3,644,761
- Nicholas Arpaia · Columbia Univ New York Morningside$3,601,553
Research focus
CytolysisDiffusionAdverse EffectsCouplingDesignAcuteAreaAffinityAlbuminsCostAffectBiological SystemsBiomedical ResearchAntibody EngineeringBlood CellsBlood CirculationBlood FractionationCatabolismChargeBindingBiodistributionCoagulation ProcessBiological Response Modifier TherapyDose
Grant awards (5)
FcRn-enabling strategies for improved thrombolytic therapy$248,984
R00 · FY2024 · HL · contact PI
FcRn-enabling strategies for improved thrombolytic therapy$248,984
R00 · FY2023 · HL · contact PI
FcRn-enabling strategies for improved thrombolytic therapy$249,000
R00 · FY2022 · HL · contact PI
FcRn-enabling strategies for improved thrombolytic therapy$152,874
K99 · FY2022 · HL · contact PI
FcRn-enabling strategies for improved thrombolytic therapy$152,874
K99 · FY2021 · HL · contact PI